[Correspondence] Stereotactic ablative radiotherapy for primary kidney cancer

May, 05, 2024 | Select Oncology Journal Articles

The FASTRACK II study by Shankar Siva and colleagues1 provided short-term evidence of renal tumour sensitivity to high-dose radiation in the non-surgical treatment of T1 renal tumours.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy